Vemurafenib Unknown Status Phase 1 / 2 Trials for BRAF Mutant Metastatic Melanoma Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs